New polymorphism and a new chromosome breakpoint establish the physical and genetic mapping of DXS369 in the DXS98-FRAXA interval
- PMID: 1673307
- DOI: 10.1002/ajmg.1320380234
New polymorphism and a new chromosome breakpoint establish the physical and genetic mapping of DXS369 in the DXS98-FRAXA interval
Abstract
Recently some of us cloned a new probe RN1 (DXS369), which appears a close marker for the fragile X locus (FRAXA) [Oostra et al.: Genomics 1990]. We present here new evidence for its physical and genetic mapping in the DXS98--FRAXA interval. We used 2 different somatic cell hybrid lines with breakpoints in the Xq27-q28 region: L10B Rea and PeCHN, and we established the order: (DXS105, DXS98)-L10B Rea-DXS369-PeCHN- (DXS304, DXS52). We detected an additional TaqI RFLP at the DXS369 locus which increases its informativeness up to 57%. Two point linkage analysis in a large set of families gave high lod scores for the FRAXA-DXS369 linkage (z(theta) = 10.1 at theta = 0.044) and for DXS369-DXS304, a marker distal to FRAXA (z = 19.2 at theta = 0.070). By multipoint analyses we established the localization of DXS369 in the DXS98-FRAXA interval. DXS369 is a much closer proximal marker for FRAXA than DXS105 or DXS98 and any new probe mapping between the breakpoints in L10B Rea and PeCHN will be of potential interest as a marker for FRAXA.
Similar articles
-
Mapping of a new RFLP marker RN1 (DXS369) close to the fragile site FRAXA on Xq27-q28.Am J Med Genet. 1991 Feb-Mar;38(2-3):332-5. doi: 10.1002/ajmg.1320380233. Am J Med Genet. 1991. PMID: 1673306
-
Genetic mapping of new RFLPs at Xq27-q28.Genomics. 1991 Jan;9(1):37-43. doi: 10.1016/0888-7543(91)90218-4. Genomics. 1991. PMID: 1672291
-
Linkage relationships between DXS105, DXS98, and other polymorphic DNA markers flanking the fragile X locus.Am J Med Genet. 1991 Feb-Mar;38(2-3):349-53. doi: 10.1002/ajmg.1320380237. Am J Med Genet. 1991. PMID: 1673310
-
Linkage analysis of the fragile X syndrome using a new DNA marker U6.2 defining locus DXS304.Am J Med Genet. 1991 Feb-Mar;38(2-3):322-7. doi: 10.1002/ajmg.1320380231. Am J Med Genet. 1991. PMID: 1673305
-
X-linked myotubular myopathy: refinement of the critical gene region.Neuromuscul Disord. 1996 Aug;6(4):275-81. doi: 10.1016/0960-8966(96)00364-1. Neuromuscul Disord. 1996. PMID: 8887957 Review.
Cited by
-
Epigenetics in nucleotide repeat expansion disorders.Semin Neurol. 2011 Nov;31(5):470-83. doi: 10.1055/s-0031-1299786. Epub 2012 Jan 21. Semin Neurol. 2011. PMID: 22266885 Free PMC article. Review.
-
Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.Eur J Hum Genet. 2017 Apr;25(4):423-431. doi: 10.1038/ejhg.2016.204. Epub 2017 Feb 8. Eur J Hum Genet. 2017. PMID: 28176767 Free PMC article.
-
The role of prenatal choline and its impact on neurodevelopmental disorders.Front Nutr. 2024 Nov 18;11:1463983. doi: 10.3389/fnut.2024.1463983. eCollection 2024. Front Nutr. 2024. PMID: 39624684 Free PMC article. Review.
-
Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial.Front Psychiatry. 2022 Jan 4;12:762967. doi: 10.3389/fpsyt.2021.762967. eCollection 2021. Front Psychiatry. 2022. PMID: 35058813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources